117 related articles for article (PubMed ID: 24410593)
1. Prognostic value of p16 promoter hypermethylation in colorectal cancer: a meta-analysis.
Jiang W; Wang PG; Zhan Y; Zhang D
Cancer Invest; 2014 Feb; 32(2):43-52. PubMed ID: 24410593
[TBL] [Abstract][Full Text] [Related]
2. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
[TBL] [Abstract][Full Text] [Related]
3. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
4. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
[TBL] [Abstract][Full Text] [Related]
5. Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley.
Wani HA; Beigh MA; Amin S; Bhat AA; Bhat S; Khan H; Mattoo AA; Showkat M; Masood A; Majid S
J Biol Regul Homeost Agents; 2013; 27(2):297-307. PubMed ID: 23830381
[TBL] [Abstract][Full Text] [Related]
6. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
9. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP.
Nomoto K; Maekawa M; Sugano K; Ushiama M; Fukayama N; Fujita S; Kakizoe T
Jpn J Clin Oncol; 2002 Jan; 32(1):3-8. PubMed ID: 11932355
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
[TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.
Hu ZY; Tang LD; Zhou Q; Xiao L; Cao Y
Tumour Biol; 2015 Mar; 36(3):1487-91. PubMed ID: 25596080
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis.
Xing X; Cai W; Shi H; Wang Y; Li M; Jiao J; Chen M
Br J Cancer; 2013 Jun; 108(12):2542-8. PubMed ID: 23703248
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer.
Tokuyama Y; Takahashi T; Okumura N; Nonaka K; Kawaguchi Y; Yamaguchi K; Osada S; Gazdar A; Yoshida K
Anticancer Res; 2010 Dec; 30(12):4811-8. PubMed ID: 21187457
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
Puri SK; Si L; Fan CY; Hanna E
Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
[TBL] [Abstract][Full Text] [Related]
18. Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
Agnese V; Corsale S; Calò V; Augello C; Bruno L; Calcara D; Crosta A; Rodolico V; Rinaldi G; Cicero G; Latteri F; Agrusa A; Morello V; Adamo V; Altavilla G; Di Fede G; Fiorentino E; Grassi N; Latteri MA; Valerio MR; Tomasino RM; Colucci G; Bazan V; Russo A;
Ann Oncol; 2006 Jun; 17 Suppl 7():vii137-41. PubMed ID: 16760277
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
20. Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.
Krtolica K; Krajnovic M; Usaj-Knezevic S; Babic D; Jovanovic D; Dimitrijevic B
World J Gastroenterol; 2007 Feb; 13(8):1187-94. PubMed ID: 17451198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]